Assessing medication burden and polypharmacy: finding the perfect measure
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Assessing medication burden to evaluate the quality of pharmacotherapy in older adults can be performed using a range of indicators including polypharmacy. Polypharmacy is a common term in the lite...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Even when the nature of symptoms is correctly interpreted, the renewed prescription of the same antidepressant drug or a switch to fluoxetine, which is less likely to induce withdrawal problems and is commonly suggested [59], may worsen the state of behavioral toxicity with subsequent episodes of refractoriness to treatment.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [59]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reducing Inappropriate Polypharmacy: The Process of Deprescribing
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C. B., Roughead, E. E., Page, A., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,584 · cited 1×
“The algorithm to guide deprescribing process to reduce inappropriate polypharmacy in clinical practice has been proposed by the Australian Deprescribing Network [20].”
MethodSelf-citationTrends in Prescription Drug Use Among Adults in the United States From 1999-2012
Kantor, E. D., Rehm, C. D., Haas, J. S., Chan, A. T., & Giovannucci, E. L. (2015) · JAMA · doi:10.1001/jama.2015.13766 · Cited by 1,219
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.02.018 · Cited by 1,176 · cited 1×
“when harms outweigh the benefits) in clinical practice [2].”
BackgroundSelf-citationReeve, E., Gnjidic, D., Long, J., & Hilmer, S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12732 · Cited by 855 · cited 1×
“Deprescribing can be referred to as a process of withdrawing inappropriatemedications, supervised by a health-care professional with the goal of managing polypharmacy and improving patient outcomes [17].”
BackgroundSelf-citationInterventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic Review
Fried, T. R., O'Leary, J., Towle, V., Goldstein, M. K., Trentalange, M., & Martin, D. K. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13153 · Cited by 721 · cited 1×
“Evidence from systematic review of observational studies suggests that polypharmacy is linkedwith a range of prescribing and clinical outcomes including drug–drug interactions, medication non-adherence, inappropriate prescribing, adverse drug events, hospitalization, falls, functional decline, and mortality [7].”
BackgroundThe Effects of Polypharmacy in Older Adults
Hilmer, S., & Gnjidic, D. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.224 · Cited by 362 · cited 1×
“Polypharmacy is a common term in the literature, but definitions vary from measuring total number of medications using various cutoffs to the use of high-risk or unnecessary medications [1].”
BackgroundSelf-citationHigh-Risk Prescribing and Incidence of Frailty Among Older Community-Dwelling Men
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V, Cumming, R. G., Handelsman, D. J., McLachlan, A. J., Abernethy, D. R., Banks, E., & Le Couteur, D. G. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.258 · Cited by 303 · cited 1×
“7% of older Australian adults living in the community [3].”
BackgroundSelf-citationToo much medicine in older people? Deprescribing through shared decision making
Jansen, J., Naganathan, V., Carter, S. M., McLachlan, A. J., Nickel, B., Irwig, L., Bonner, C., Doust, J., Colvin, J., Heaney, A., et al. (2016) · BMJ · doi:10.1136/bmj.i2893 · Cited by 303 · cited 1×
“of shared decision-making and patient preferences in guiding deprescribing process has been recently highlighted, although implementation in the clinical practice may be challenging [21].”
BackgroundClinical assessment and management of multimorbidity: summary of NICE guidance
Farmer, C., Fenu, E., O’Flynn, N., & Guthrie, B. (2016) · BMJ · doi:10.1136/bmj.i4843 · Cited by 238 · cited 1×
“This has been acknowledged in the recent National Institute for Health and Care Excellence guidelines which provide recommendations for management of polypharmacy among people with multimorbidity [10].”
Method
Research works printed but not linked: 1
- Patterson SM, 2014, Cochrane Database Syst Rev, 10, CD008165
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Iatrogenic Factors in Psychopathology
Fava, G. A., & Rafanelli, C. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000500151 · Cited by 82
Discontinuing Antidepressant Drugs: Lesson from a Failed Trial and Extensive Clinical Experience
Fava, G. A., & Belaise, C. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000492693 · Cited by 77
Understanding Health Attitudes and Behavior
Fava, G. A., Cosci, F., Sonino, N., & Guidi, J. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.10.019 · Cited by 72
Fall Risk-Increasing Drugs, Polypharmacy, and Falls Among Low-Income Community-Dwelling Older Adults
Ie, K., Chou, E., Boyce, R. D., & Albert, S. M. (2021) · Innovation in Aging · doi:10.1093/geroni/igab001 · Cited by 72
“It has been argued that the harm of polypharmacy may not consistently outweigh its benefit, depending on the appropriateness of medications prescribed (28).”
BackgroundKrustev, T., Milushewa, P., & Tachkov, K. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.743138 · Cited by 63
Taghy, N., Cambon, L., Cohen, J., & Dussart, C. (2020) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s214187 · Cited by 46
Wang, Y., Li, X., Jia, D., Lin, B., Fu, B., Qi, B., & Zhang, Z. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02247-1 · Cited by 45
Clinical Interviewing: An Essential but Neglected Method of Medicine
Fava, G. A., Sonino, N., Aron, D. C., Balon, R., Montiel, C. B., Cao, J., Concato, J., Eőry, A., Horwitz, R. I., Rafanelli, C., et al. (2024) · Psychotherapy and Psychosomatics · doi:10.1159/000536490 · Cited by 38
Gnjidic, D., Agogo, G. O., Ramsey, C. M., Moga, D. C., & Allore, H. G. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly078 · Cited by 42
“Moreover, it could be due to the tool chosen to measure anticholinergic burden, which are variably defined (21).”
BackgroundSelf-citationChallenges and innovations of delivering medicines to older adults
Gnjidic, D., Husband, A., & Todd, A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.003 · Cited by 37
“Managing polypharmacy in older adults is complex: there is limited clinical evidence to support the use of complex medication regimens to manage older people with multimorbidity, while there is increasing evidence of harm, including an increased risk of an adverse event occurring, such as falling, frailty, functional…”
BackgroundSelf-citationMortsiefer, A., Löscher, S., Pashutina, Y., Santos, S., Altiner, A., Drewelow, E., Ritzke, M., Wollny, A., Thürmann, P., Bencheva, V., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4723 · Cited by 44
Arnet, I., Greenland, M., Knuiman, M. W., Rankin, J. M., Hung, J., Nedkoff, L., Briffa, T. G., & Sanfilippo, F. M. (2018) · Clinical Epidemiology · doi:10.2147/clep.s153496 · Cited by 27
“30 For the operationalization of the DPPR, the following definitions and assumptions were made, in accordance with others, 2,15,31 and integrated into the SAS programming: 1.”
Lampe, D., Grosser, J., Gensorowsky, D., Witte, J., Muth, C., van den Akker, M., Dinh, T. S., & Greiner, W. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01022-8 · Cited by 35
“Studies have shown that polypharmacy is associated with potentially inappropriate prescribing [9] and several adverse health events [10–12].”
Karbownik, M. S., Jankowska‐Polańska, B., Horne, R., Górski, K. M., Kowalczyk, E., & Szemraj, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230131 · Cited by 23
“This is not surprising, as the sense of deteriorating health and the personal burden of hospitalization or polypharmacy [49]–as compared to relative well-being of socially active attendees of the U3A [50]–may intensify medication-related concerns and beliefs about their harmful effects.”
BackgroundRisk factors for potentially inappropriate medication use in older adults: a cohort study
de Araújo, N. C., Silveira, É. A., Mota, B. G., Guimarães, R. A., Modesto, A. C. F., & Pagotto, V. (2022) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-022-01433-4 · Cited by 23
“For polypharmacy, the use of five or more drugs was considered, based on the presentation of a medical prescription and/or drug packaging [21].”
MethodSargent, L. J., Flattery, M. P., Shah, K. B., Price, E. T., Tirado, C., Oliveira, T., Starkweather, A. R., & Salyer, J. (2020) · Applied Nursing Research · doi:10.1016/j.apnr.2020.151375 · Cited by 24
Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany
Krulichová, I. S., Selke, G., & Thürmann, P. (2021) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-021-03148-3 · Cited by 15
“Patients were defined to be subject to cumulative polypharmacy if they received at least five different medications at ATC code level 5 within the study period, and the use of ten or more different medications was qualified as excessive polypharmacy [21, 22].”
BackgroundAbdulah, R., Insani, W. N., Putri, N. E., Purba, H. P., Destiani, D. P., & Barliana, M. I. (2019) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s187829 · Cited by 13
Lo, S. Y., Zhang, M., Hubbard, R. E., Gnjidic, D., Redston, M. R., & Hilmer, S. N. (2020) · Australian Journal on Ageing · doi:10.1111/ajag.12888 · Cited by 13
Self-citationWang, Y., Krska, J., Lin, B., Mei, Y., Katusiime, B., Guo, Y., & Zhang, Z. (2020) · Patient Preference and Adherence · doi:10.2147/ppa.s275006 · Cited by 12
Raut, S. B., Mellor, R., Meurk, C., Lam, M., Lane, J., Khoo, A., Cronin, A., Smith, S., Heffernan, E., & Johnson, L. R. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.025 · Cited by 11
Bekalu, A. F., Yenit, M. K., Tekle, M. T., & Birarra, M. K. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.977216 · Cited by 10
Eventos adversos a medicamentos em idosos de unidades de terapia intensiva
Gomes, V. R. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.7.2018.tde-27042018-143325 · Cited by 11
Pharmacist-led medication therapy management: Impact on healthcare utilization and costs
Umeh, A. U., Chima, U. E., Agbo, C. E., Chiekwe, O. S., Eze, A. E., Nwachuya, C. A., Mmuo, S. S., Nnedu, C. E., & Isah, A. (2025) · American Journal of Pharmacotherapy and Pharmaceutical Sciences · doi:10.25259/ajpps_2025_004 · Cited by 15
Michael, H. U., Brouillette, M., Tamblyn, R. M., Fellows, L. K., & Mayo, N. E. (2023) · AIDS · doi:10.1097/qad.0000000000003806 · Cited by 9
Warmoth, K., Rees, J., Day, J., Cockcroft, E., Aylward, A., Pollock, L., Coxon, G., Craig, T., Walton, B., & Stein, K. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-081305 · Cited by 9
McAvay, G., Allore, H. G., Cohen, A. B., Gnjidic, D., Murphy, T. E., & Tinetti, M. E. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15065 · Cited by 6
“We examined whether baseline polypharmacy exposure, measured according to the number of concomitant medications, modified the associations between individual guideline-recommended medications and physical function, but number of medications alone cannot be used to inform prescribing decisions.(48) The observed reducti…”
BackgroundSelf-citationReilly, C., Buikstra, E., Strivens, E., Marsden, E. J., Brose, J., & Craswell, A. (2023) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1896 · Cited by 5
“22 Scott and Jayathissa 6 highlighted that polypharmacy increases the risk of ADR from 13% with two prescribed drugs, to 38% with four drugs, and 82% with seven drugs or more.”
BackgroundThe role of interviewing in endocrine practice
Sonino, N., Fava, G. A., Aron, D. C., & Guidi, J. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02565-w · Cited by 6
“Treatment history appears to be particularly complex in view of the frequency of polypharmacy [23] and requires accurate exploration, a process that can be compromised if an insufficient amount of time is allotted.”
Warmoth, K., Day, J., Cockcroft, E., Reed, D. N., Pollock, L., Coxon, G., Heneker, J., Walton, B., & Stein, K. (2020) · Implementation Science Communications · doi:10.1186/s43058-020-00067-9 · Cited by 5
Clinical judgment: an essential method in medicine
Fava, G. A., Sonino, N., & Guidi, J. (2026) · Postgraduate Medical Journal · doi:10.1093/postmj/qgag030 · Cited by 3
Epidemiology of hypertension among patients with type 2 diabetes in the Democratic Republic of Congo
Simelane, X., Lubaki, J.-P. F., & Francis, J. M. (2025) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v17i1.4712 · Cited by 4
“33 Psychological parameters : The Multidimensional Scale for Perceived Social Support (MSPSS) 34 was used to assess social support.”
Bondi, S., Yang, D., Croll, L., & Torres, J. (2020) · The Neurohospitalist · doi:10.1177/1941874420953320 · Cited by 3
Study of laxative and hepatoprotective activity of extracts obtained from Prunus domestica fruits
Сенюк, І., Al-Sahlanee, B. J. A., Bakri, A. A., Кравченко, В., & Шовкова, О. (2021) · Pharmacia · doi:10.3897/pharmacia.68.e64159 · Cited by 3
Stinson, J. D., LeMay, C. C., & Quinn, M. (2024) · International Journal of Forensic Mental Health · doi:10.1080/14999013.2024.2311403 · Cited by 3
“Polypharmacy has been variably defined, most broadly the use of two or more concurrent medications (Gnjidic et al., 2017; Guthrie et al., 2015).”
Zintchouk, D., Gregersen, M., Lauritzen, T., & Damsgaard, E. M. S. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.09.030 · Cited by 4
Dumitrescu, I., Casteels, M., Vliegher, K. D., Hubens, C., & Dilles, T. (2024) · International Journal of Older People Nursing · doi:10.1111/opn.70003 · Cited by 5
Al-Sahlanee, B. J. A., Litkin, D. V., & Сенюк, І. (2019) · Clinical pharmacy · doi:10.24959/167342 · Cited by 3
Protocol for the development and validation of a Polypharmacy Assessment Score
Tsang, J. Y., Sperrin, M., Blakeman, T., Payne, R., & Ashcroft, D. M. (2024) · Diagnostic and Prognostic Research · doi:10.1186/s41512-024-00171-7 · Cited by 2
“However, these meth-ods focus on individual examples of high-risk prescribing within a limited number of conditions, rather than polyp-harmacy as a whole [1, 12].”
BackgroundMedication Use by Alternate Level of Care Patients: A Descriptive Analysis
Azimi, M., Burry, L. D., Duclos, C., Pelc, J., Nie, J. X., & Upshur, R. E. G. (2019) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v72i4.2914 · Cited by 1
“1 Sex (female) 43 (52) ALC discharge destination Long-term care bed 67 (82) Supportive housing 4 (5) Geriatric rehabilitation 1 (1) Home with CCAC 4 (5) Unknown 6 (7) Morse fall risk High 60 (73) Moderate 14 (17) Low 8 (10) Length of stay (days) (median and IQR) 281 (107.”
BackgroundLemes, J. S., Silveira, É. A., Malaquias, S. G., Nunes, D. P., Sousa, J. M., Nunes, C. A. D. B., Farinha, M. G., & Pagotto, V. (2023) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.16n.10-099 · Cited by 1
“Polypharmacy was defined by the consumption of five or more medicines (Gnjidic et al., 2017).”
BackgroundMoreira, T., Álvares-Teodoro, J., Barbosa, M. M., do Nascimento, R. C. R. M., Guerra, A. A., & Acúrcio, F. D. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1836958 · Cited by 4
Medication therapy in older adults
Lau, S. W. J., Gnjidic, D., & Abernethy, D. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819869-8.00006-9 · Cited by 1
Self-citationde Araújo, N. C., Silveira, É. A., Mota, B. G., Guimarães, R. A., Modesto, A. C. F., & Pagotto, V. (2022) · Research Square · doi:10.21203/rs.3.rs-1314515/v1
Warmoth, K., Rees, J., Day, J., Cockcroft, E., Aylward, A., Pollock, L., Coxon, G., Craig, T., Walton, B., & Stein, K. (2023) · Research Square · doi:10.21203/rs.3.rs-2646989/v1
Agentes antitrombóticos utilizados por pessoas idosas: prevalência e fatores associados
Pagotto, V., Silveira, É. A., dos Santos, A. C. P., Mota, B. G., Silva, A. E. B. D. C., & Barp, M. (2023) · Revista Brasileira de Geriatria e Gerontologia · doi:10.1590/1981-22562023026.230122.pt
“Para polifarmácia considerou-se o consumo de cinco ou mais medicamentos, a partir da apresentação de receita médica e/ou embalagem do medicamento 20 .”
BackgroundAntithrombotic agents used by older people: prevalence and associated factors
Pagotto, V., Silveira, É. A., dos Santos, A. C. P., Mota, B. G., Silva, A. E. B. D. C., & Barp, M. (2023) · Revista Brasileira de Geriatria e Gerontologia · doi:10.1590/1981-22562023026.230122.en
Chun, G. Y., Ng, S. S. M., Islahudin, F. H., Selvaratnam, V., & Tahir, N. A. M. (2024) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-024-01716-y
“Indeed, there have been ambiguous findings on the causal effect of polypharmacy on mortality and aligned interventions have provided inconclusive mortality outcomes [5, 6].”
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00007-8
Stratégies et options pharmacologiques
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00008-x
Wang, X., Su, L., Yang, X., Qiao, R., Zheng, J., Zhang, C., Zhang, X., Qu, L., & Lin, B. (2026) · Healthcare · doi:10.3390/healthcare14070965
“A negative medication experience refers to patients experiencing negative emotions and non-adherent behaviors due to factors such as low satisfaction with medication, a high burden of treat-ment, or poor medication practices, ultimately affecting their overall physical and mental health [8,9].”
Liyanage, L. S., Naunton, M., Cox, L. S., Sudeshika, T., Peterson, G. M., & Kosari, S. (2026) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzag063
Samuel, S., Cadena-Tejada, A. J., Peoples, K., Torres, L. F., & Smart, S. O. (2026) · Annals of Pharmacotherapy · doi:10.1177/10600280261452558
Metadata
- Authors
- Gnjidic, D., Tinetti, M., & Allore, H. G.
- Affiliations
- The University of Sydney (AU)
- Yale University (US)
- Corresponding author
- Gnjidic, Danijela
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2017-03-08
- Volume
- 10
- Issue
- 4
- Pages
- 345-347
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- PMC
- PMC5477055
- OpenAlex
- W2594219652
- Cited by
- 54
- References
- 21
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 8 · 2023: 9 · 2022: 5 · 2021: 5 · 2020: 9 · 2019: 4 · 2018: 6 · 2017: 1
- Type
- journal article
- Language
- en
- Update notices
- correction (2017-03-21)
- Open access
- bronze
- doi.org
- Locations
- Expert Review of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01 AG047891, R21 AG045148, P30 AG021342)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- medication burden, polypharmacy, older adults
- MeSH terms
- Aged, Humans, Practice Patterns, Physicians', Polypharmacy, Inappropriate Prescribing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.